TABLE 1.
Posttransplant Monitoring (September 2008)
| Tests Monitored at Every Visit | |
|---|---|
| Urinalysis | |
| Complete blood count | |
| Renal profile | |
| Calcium, magnesium, phosphorus | |
| Glucose | |
| Medication levels (tacrolimus, sirolimus, cyclosporine) | |
| Tests Not Monitored at Every Visit | |
| Test | Frequency |
| Liver profile | (Not on statin) at 6 mo, 1 y, 2 y, and every 2 y |
| (On a statin) before statin, monthly for 3 mo, then at 6 mo after statin and every 6 mo thereafter | |
| Creatine kinase (only if on statin) | See liver profile “on a statin” |
| Uric acid | At 6 mo, 1 y, 2 y, and every 2 y |
| Fasting lipid profile | (Not on sirolimus) At 6 mo, 1 y, 2 y, and every 2 y |
| (On sirolimus) every 6 mo | |
| Nuclear glomerular filtration rate | At 6 mo, 1 y, 2 y, and every 2 y |
| Cystatin C | At 6 mo, 1 y, 2 y, and every 2 y |
| Urine BK virus | At 1 mo, at 6 mo, at 1 y, and yearly |
| Testosterone, LH, FSH (only if on sirolimus) | At time of sirolimus initiation, every 6 mo while on sirolimus |
| Echocardiogram | At 1 y, 2 y, and every 2 y |
| Transplant ultrasound | At 3 mo, 1 y, 2 y, and every 2 y |
| EBV IgG & IgM, EBV quantitative PCR (only for EBV IgG-negative patients) | At 1 mo, quarterly during the first 2 y, and yearly until converted |
EBV, Epstein-Barr virus; FSH, follicle stimulating hormone; Ig, immunoglobulin; LH, luteinizing hormone; PCR, polymerase chain reaction.